The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First experience with osimertinib in patients with T790M mutation previously treated with EGFR – TKIs in Croatia.
 
Marko Jakopovic
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
 
Lela Bitar
No Relationships to Disclose
 
Branka Cucevic
No Relationships to Disclose
 
Sanja Plestina
No Relationships to Disclose
 
Ivica Mazuranic
No Relationships to Disclose
 
Sven Seiwerth
No Relationships to Disclose
 
Ana Hecimovic
No Relationships to Disclose
 
Andrea Vukic Dugac
No Relationships to Disclose
 
Mateja Jankovic
No Relationships to Disclose
 
Gzim Redzepi
No Relationships to Disclose
 
Miroslav Samarzija
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - Boehringer Ingelheim; Novartis; Pfizer; Roche